Robert Shiller Warns Market Declines May Alter Risk Perception Creating Potential Opportunities SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Lags Energy Transfer ET Analyst Target Raised on Improved EBITDA Outlook Microsoft and Anthropic in Talks for Custom AI Chip Deal After 5 Billion Investment Anthropics Surprise Profit Projection Signals Competitive Edge Ahead of Potential IPO Wipro and Eicher Motors Stock Outlook Analyst Highlights Bullish Signals on May 25 Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges MUFG Q1 2026 Earnings Strong EPS Surprise of 397 Despite Stock Dip INFY Q1 2026 Earnings EPS Surges Past Estimates as Demand Remains Resilient MED Q1 2026 Earnings EPS Surprises to the Upside but Stock Declines CRH Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment Kentucky First Federal Bancorp KFFB Hovers Near Support After Modest Decline Devon Energy DVN Loses Ground as Bearish Pressure Tests Support Levels Pentair PNR Slips 173 as Stock Tests Key Support Levels LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1010 as SPAC Unit Trades in Tight Range Ermenegildo Zegna ZGN Gains 26 as Luxury Sector Shows Resilience Trek 2000 Secures New Investor as Osim Founder Ron Sim Drops Legal Claims Sells Stake at Premium Magnite Inc MGNI Q1 2026 Earnings EPS Surpasses Estimates by 206 Talon Capital Corp Warrants TLNCW Decline 25 as Selling Pressure Mounts MBLY Q1 2026 Earnings Profit Beat Drives Stock Rally Palantir Q1 2026 Earnings EPS Beats Estimates by 1583 Stock Declines TONX Q1 2026 Earnings EPS Beat Drives 62 Stock Gain as Losses Narrow Sharply FiEE Inc Q1 2023 Earnings EPS Misses Estimates by 41 Stock Slightly Down SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss CHT Q1 2026 Earnings EPS Misses Estimates Amid Stable Operations Revelation Biosciences Inc REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues Development